Singapore, a nation celebrated for its impressive longevity rates, is actively exploring innovative avenues to ensure those extra years are not overshadowed by ill health, particularly neurodegenerative conditions. Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), are at the forefront of this endeavor, investigating whether interventions targeting the fundamental biological processes of aging can serve as a powerful strategy against age-related ailments like Alzheimer’s disease. This forward-thinking approach aims to shift the paradigm from merely treating the symptoms of diseases to proactively addressing the underlying mechanisms of aging that make individuals susceptible.
A significant breakthrough has emerged from this research, focusing on a naturally occurring and well-studied metabolite known as calcium alpha-ketoglutarate (CaAKG). In a study published in the esteemed journal Aging Cell, a team led by Professor Brian K Kennedy, from the Department of Biochemistry and the Chair of the Healthy Longevity Translational Research Programme (TRP) at NUS Medicine, has illuminated the potential of CaAKG to revitalize critical brain functions intrinsically linked to memory, which are significantly compromised in individuals with Alzheimer’s disease. The investigation was designed to rigorously assess CaAKG’s capacity to enhance synaptic plasticity within the context of an Alzheimer’s-affected brain, to re-establish memory-related neural signaling pathways, to shield neurons from premature degradation, and to foster a more robust trajectory of cognitive aging.
The implications of these findings are profound, suggesting a potential recalibration of medical strategies. By focusing on geroprotection – interventions that target the aging process itself – researchers are moving beyond a disease-specific, symptom-focused model. This shift opens up exciting possibilities for developing treatments that could offer broader benefits and address multiple age-related conditions simultaneously.
Professor Kennedy expressed considerable optimism regarding the findings, stating, "Our results highlight the remarkable potential of compounds associated with healthy longevity in tackling Alzheimer’s disease." He elaborated that the research indicates that safe, naturally occurring substances like CaAKG could eventually serve as valuable complements to existing therapeutic approaches, offering a means to protect the brain and mitigate the progression of memory loss. A key advantage, he noted, is that AKG is already a component of the human body. This intrinsic presence suggests that interventions targeting these endogenous pathways might carry a reduced risk profile and possess greater accessibility for a wider population. Consequently, this could pave the way for a potent new strategy designed to forestall cognitive decline and champion healthy brain aging throughout life.
The study provided compelling evidence that CaAKG significantly improves intercellular communication within brain cells in models simulating Alzheimer’s disease. Specifically, it demonstrated efficacy in repairing compromised signaling between neurons and restoring associative memory, a fundamental cognitive function that is often among the earliest to be affected by the disease. Given that the body’s natural levels of AKG tend to diminish with advancing age, the prospect of replenishing this molecule emerges as a highly promising avenue for bolstering brain health over time and potentially diminishing the risk of neurodegenerative disorders.
To delve deeper into the mechanisms by which CaAKG exerts its beneficial effects, the research team meticulously examined long-term potentiation (LTP). LTP is a crucial cellular process responsible for strengthening the connections between neurons, forming the very foundation of learning and long-term memory formation. In Alzheimer’s disease, this vital process is severely impaired. The researchers observed that CaAKG effectively restored LTP to levels comparable to those seen in healthy brains.
Furthermore, CaAKG was found to enhance autophagy, a sophisticated cellular "housekeeping" mechanism within the brain. Autophagy is essential for the efficient removal of damaged proteins and cellular debris, thereby maintaining neuronal health and function. The molecule appears to achieve this by activating a newly identified pathway. This pathway enhances neuronal flexibility through the activation of L-type calcium channels and calcium-permeable AMPA receptors. Crucially, this mechanism bypasses NMDA receptors, which are frequently susceptible to damage from the buildup of amyloid plaques characteristic of Alzheimer’s disease.
A particularly significant finding was CaAKG’s restoration of synaptic tagging and capture. This intricate process is fundamental for the brain’s ability to consolidate experiences and forge associative memories. The compound’s influence on this mechanism suggests that it may not only support rudimentary memory functions but also enhance higher-order learning capabilities that typically deteriorate early in the course of Alzheimer’s disease.
Dr. Sheeja Navakkode, the study’s first author and a research scientist at the Healthy Longevity TRP, NUS Medicine, articulated the research’s overarching objective: "Our aim was to ascertain whether a compound initially explored for its potential to extend healthy lifespan could offer benefits for Alzheimer’s disease." She further emphasized the importance of understanding the cellular pathways through which CaAKG enhances synaptic plasticity, stating that such knowledge "sheds light on novel strategies for safeguarding memory and decelerating the aging process of the brain." This research represents a significant stride in harnessing the principles of longevity science to develop targeted interventions for neuroprotection.
About the Author
